SE0203746D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0203746D0
SE0203746D0 SE0203746A SE0203746A SE0203746D0 SE 0203746 D0 SE0203746 D0 SE 0203746D0 SE 0203746 A SE0203746 A SE 0203746A SE 0203746 A SE0203746 A SE 0203746A SE 0203746 D0 SE0203746 D0 SE 0203746D0
Authority
SE
Sweden
Prior art keywords
new compounds
compounds
tetrahydronaphtalenes
acromegaly
igf
Prior art date
Application number
SE0203746A
Other languages
Swedish (sv)
Inventor
Magnus Axelsson
Olle Larsson
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE0203746A priority Critical patent/SE0203746D0/en
Publication of SE0203746D0 publication Critical patent/SE0203746D0/en
Priority to PCT/SE2003/002010 priority patent/WO2004054996A1/en
Priority to AU2003288857A priority patent/AU2003288857A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to new compounds belonging to the group of substituted 1-phenyl-tetrahydronaphtalenes and the use thereof as inhibitors of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, arteriosclerosis and acromegaly.
SE0203746A 2002-12-18 2002-12-18 New compounds SE0203746D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0203746A SE0203746D0 (en) 2002-12-18 2002-12-18 New compounds
PCT/SE2003/002010 WO2004054996A1 (en) 2002-12-18 2003-12-18 New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor
AU2003288857A AU2003288857A1 (en) 2002-12-18 2003-12-18 New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203746A SE0203746D0 (en) 2002-12-18 2002-12-18 New compounds

Publications (1)

Publication Number Publication Date
SE0203746D0 true SE0203746D0 (en) 2002-12-18

Family

ID=20289899

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0203746A SE0203746D0 (en) 2002-12-18 2002-12-18 New compounds

Country Status (3)

Country Link
AU (1) AU2003288857A1 (en)
SE (1) SE0203746D0 (en)
WO (1) WO2004054996A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007029107A1 (en) * 2005-09-09 2007-03-15 Analytecon Sa Isoquinolines derivatives as igf-1r inhibitors
KR20080042897A (en) * 2005-09-09 2008-05-15 아날리테콘에스.에이. Isoquinolines as igf-1r inhibitors
WO2009100349A1 (en) 2008-02-09 2009-08-13 The Trustees Of Columbia University In The City Of New York Analogues of (-)-picropodophyllin, synthesis and uses thereof
WO2011083391A2 (en) 2010-01-05 2011-07-14 Pfizer Inc. Biomarkers for anti-igf-ir cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720966B2 (en) * 1984-12-28 1995-03-08 コンプハルム・エイビ− Disease remedy containing pharmaceutically active compound
SE0102168D0 (en) * 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds

Also Published As

Publication number Publication date
WO2004054996A1 (en) 2004-07-01
AU2003288857A1 (en) 2004-07-09

Similar Documents

Publication Publication Date Title
EA200601850A1 (en) 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC INHIBITORS PROTEINKINAZ
UA93351C2 (en) Phthalazine derivatives as parp inhibitors
NZ592425A (en) Isoindoline compounds for use in the treatment of cancer
WO2006020358A3 (en) Novel biphenyl compounds and their use
UY29246A1 (en) NEW COMPOUNDS
ECSP056210A (en) PREPARATION AND USE OF RENTAL DERIVATIVES FOR THE TREATMENT OF OBESITY
ATE541571T1 (en) DIARYLHYDANTOIN COMPOUND
HN2002000067A (en) INHIBITORS OF THE RHO - QUINASA.
AR028824A1 (en) NPY-5 ANTAGONIST COMPOUNDS AND ITS USE IN THE MANUFACTURE OF MEDICINES.
EA200600689A1 (en) SUBSTITUTED BENZEZOLES AND THEIR APPLICATION AS RAF KINASE INHIBITORS
EA200702387A1 (en) IMIDAZOCHINOLINES AS LIPIDKINASE INHIBITORS
NO20062130L (en) 4- (pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
NO20045043L (en) Pyrimidinone Compounds, Compositions and Methods
MY137040A (en) Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
TW200612950A (en) Quinazolinedione derivatives as PARP inhibitors
TW200700422A (en) Compounds for inhibiting ksp kinesin activity
GB0112348D0 (en) Compounds
BR0309278A (en) Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound
ATE484508T1 (en) FURYL COMPOUNDS
TW200700066A (en) Compounds for inhibiting ksp kinesin activity
ATE477256T1 (en) THIENYL COMPOUNDS
AU2006273692A8 (en) 1,4-Dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
EA201000612A1 (en) ANTAGONISTS CGRP-PEPTIDES
EA200700550A1 (en) DERIVATIVES OF ALKYLIDENTETRAHYDRONAPTALINE, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS ANTI-INFLAMMATORY MEANS